Haemair Ltd. Founded in 2005 by engineers who had witnessed the devastating impact of lung disease on their loved ones, Haemair is committed to developing innovative solutions to improve patient outcomes. Their flagship product is a fully portable lung-assist device that can be integrated into the blood circulation.

By adding oxygen and removing carbon dioxide, this device enhances the patient's lung capacity, restoring mobility and extending life. In addition to their lung-assist device, Haemair has also developed a range of related technologies aimed at saving lives. These technologies leverage the team's expertise in mass transfer to and from blood and blood flow.

The team at Haemair consists of talented engineers and scientists with a diverse skill set, including mechanical engineering, chemistry, chemical engineering, and medicine. While the regulatory approval process for their portable lung-assist device is lengthy and expensive, Haemair plans to bring simpler devices to the market sooner. With a strong focus on research and development, Haemair is dedicated to revolutionizing the field of medical devices and improving the lives of patients worldwide